Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
Legal Correspondent

COVID-19 | Homoeopaths can prescribe government-approved add-ons, mixtures to supplement conventional treatment, says Supreme Court

Supreme Court. File (Source: THE HINDU)

The Supreme Court on Tuesday clarified that homoeopaths could prescribe government-approved add-ons and mixtures to supplement conventional treatment for COVID-19, but could not advertise any cures to the virus.

A Bench led by Justice Ashok Bhushan, in a judgment, in fact, endorsed a March 6 advisory of the Ministry of AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy) that homoeopaths could not prescribe medicines for COVID-19 treatment but could provide prophylactic interventions for improving the immunity of the patients.

The Supreme Court had said it would clear the air on the role of homoeopathy in the fight against the pandemic. The verdict came on a plea challenging the Kerala High Court order of August 21, which had said that AYUSH medical practitioners could prescribe government-approved mixtures and tablets only as immunity booster.

The Centre had told the top court that medicines which were permitted to be prescribed by the Ministry of AYUSH to COVID-19 patients as an add-on treatment was allowed.

The government affidavit in court had said “the prescription of the medication prescribed by the Ministry of AYUSH to COVID-19 positive patients as an add-on treatment is permitted, and therefore, any contention to the contrary stating that homoeopathic medical practitioner cannot prescribe any treatment to COVID-19 positive patients, even as an add-on to conventional treatment is liable to be rejected”.

The Ministry said in its affidavit that, “It is stated that the only embargo is that the said medicines should not be administered or advertised as a cure but should be administered as preventive measure/immunity booster or as an add-on to the conventional treatment”.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.